Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Marc Peter Bonaca

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Bonaca, Marc

One or more keywords matched the following items that are connected to Bonaca, Marc

Item Type	Name
Concept	Coronary Thrombosis
Concept	Venous Thrombosis
Concept	Thrombosis
Academic Article	Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trial.
Academic Article	Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2?P-TIMI 50 trial.
Academic Article	Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2?P-TIMI 50 trial.
Academic Article	Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With?Multivessel Coronary Disease.
Academic Article	SCH 530348: a novel oral thrombin receptor antagonist.
Academic Article	Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial.
Academic Article	Left ventricular thrombosis refractory to medical therapy.
Academic Article	Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2? P-TIMI 50 trial.
Academic Article	Polyvascular disease and risk: When two is not better than one.
Academic Article	Pathology of Arterial Disease in Limb?Loss: The Clot Thickens.
Academic Article	Atherothrombotic risk stratification after acute myocardial infarction: The Thrombolysis in Myocardial Infarction Risk Score for Secondary Prevention in the light of the French Registry of Acute ST Elevation or non-ST Elevation Myocardial Infarction registries.
Academic Article	Vorapaxar for secondary prevention in the elderly with peripheral artery disease: Insights from the TRA 2?P-TIMI 50 trial.
Academic Article	The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism.
Academic Article	Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Academic Article	Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease.
Academic Article	Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study.
Academic Article	Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization.
Academic Article	Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2?P-TIMI 50.
Academic Article	Long-Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS-TIMI 54 Trial.
Academic Article	Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone.
Academic Article	Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
Academic Article	Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
Academic Article	Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study.
Academic Article	Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.

Search Criteria

Thrombosis